A similar induction of mitochondrial vulnerability has been previously observed when introducing KRAS mutations into colorectal cancer cell lines of both Wnt‐low and Wnt‐high groups (Martin et al, 2017), indicating that Wnt signaling is not the only pathway important for directing metabolic rewiring in cancer. This evidence concerns the gene KRAS and cancer.